IBDEI2WK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46299,1,3,0)
 ;;=3^Angle Recession,Right Eye
 ;;^UTILITY(U,$J,358.3,46299,1,4,0)
 ;;=4^H21.551
 ;;^UTILITY(U,$J,358.3,46299,2)
 ;;=^5005255
 ;;^UTILITY(U,$J,358.3,46300,0)
 ;;=H21.552^^176^2304^17
 ;;^UTILITY(U,$J,358.3,46300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46300,1,3,0)
 ;;=3^Angle Recession,Left Eye
 ;;^UTILITY(U,$J,358.3,46300,1,4,0)
 ;;=4^H21.552
 ;;^UTILITY(U,$J,358.3,46300,2)
 ;;=^5005256
 ;;^UTILITY(U,$J,358.3,46301,0)
 ;;=H20.041^^176^2304^22
 ;;^UTILITY(U,$J,358.3,46301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46301,1,3,0)
 ;;=3^Iridocyclitis,Traumatic,Right Eye
 ;;^UTILITY(U,$J,358.3,46301,1,4,0)
 ;;=4^H20.041
 ;;^UTILITY(U,$J,358.3,46301,2)
 ;;=^5005146
 ;;^UTILITY(U,$J,358.3,46302,0)
 ;;=H20.042^^176^2304^23
 ;;^UTILITY(U,$J,358.3,46302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46302,1,3,0)
 ;;=3^Iridocyclitis,Traumatic,Left Eye
 ;;^UTILITY(U,$J,358.3,46302,1,4,0)
 ;;=4^H20.042
 ;;^UTILITY(U,$J,358.3,46302,2)
 ;;=^5005147
 ;;^UTILITY(U,$J,358.3,46303,0)
 ;;=H21.1X1^^176^2304^37
 ;;^UTILITY(U,$J,358.3,46303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46303,1,3,0)
 ;;=3^Vascular Disorders of Iris & Ciliary Body,Rt Eye
 ;;^UTILITY(U,$J,358.3,46303,1,4,0)
 ;;=4^H21.1X1
 ;;^UTILITY(U,$J,358.3,46303,2)
 ;;=^5005175
 ;;^UTILITY(U,$J,358.3,46304,0)
 ;;=H21.1X2^^176^2304^38
 ;;^UTILITY(U,$J,358.3,46304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46304,1,3,0)
 ;;=3^Vascular Disorders of Iris & Ciliary Body,Lt Eye
 ;;^UTILITY(U,$J,358.3,46304,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,46304,2)
 ;;=^5005176
 ;;^UTILITY(U,$J,358.3,46305,0)
 ;;=H21.1X3^^176^2304^39
 ;;^UTILITY(U,$J,358.3,46305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46305,1,3,0)
 ;;=3^Vascular Disorders of Iris & Ciliary Body,Bilateral
 ;;^UTILITY(U,$J,358.3,46305,1,4,0)
 ;;=4^H21.1X3
 ;;^UTILITY(U,$J,358.3,46305,2)
 ;;=^5005177
 ;;^UTILITY(U,$J,358.3,46306,0)
 ;;=H40.051^^176^2305^1
 ;;^UTILITY(U,$J,358.3,46306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46306,1,3,0)
 ;;=3^Ocular Hypertension,Right Eye
 ;;^UTILITY(U,$J,358.3,46306,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,46306,2)
 ;;=^5005740
 ;;^UTILITY(U,$J,358.3,46307,0)
 ;;=H40.052^^176^2305^2
 ;;^UTILITY(U,$J,358.3,46307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46307,1,3,0)
 ;;=3^Ocular Hypertension,Left Eye
 ;;^UTILITY(U,$J,358.3,46307,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,46307,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,46308,0)
 ;;=H40.053^^176^2305^3
 ;;^UTILITY(U,$J,358.3,46308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46308,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,46308,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,46308,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,46309,0)
 ;;=H40.1211^^176^2305^16
 ;;^UTILITY(U,$J,358.3,46309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46309,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Right Eye
 ;;^UTILITY(U,$J,358.3,46309,1,4,0)
 ;;=4^H40.1211
 ;;^UTILITY(U,$J,358.3,46309,2)
 ;;=^5005759
 ;;^UTILITY(U,$J,358.3,46310,0)
 ;;=H40.1221^^176^2305^17
 ;;^UTILITY(U,$J,358.3,46310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46310,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Left Eye
 ;;^UTILITY(U,$J,358.3,46310,1,4,0)
 ;;=4^H40.1221
 ;;^UTILITY(U,$J,358.3,46310,2)
 ;;=^5005764
 ;;^UTILITY(U,$J,358.3,46311,0)
 ;;=H40.1231^^176^2305^18
